Bolivia Medical Device Registration Validity and Renewal: Five-Year Term and the 30-Business-Day Window

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The sanitary registration for medical devices in Bolivia is valid for five years from the date of issuance, under Section 3.1.5 of the Manual. Re-registration, known as reinscripción, may be requested before expiry, and may also be submitted within thirty business days after the five-year term has ended, with the original registration remaining valid while the re-registration is being processed. The GRZAN management method is a two-layer calendar. The first layer records the issuance date and expiry date of each product certificate. The second layer records, for each license-holding company, the annual review node of 31 December each year, under Section 5.7.2. The two layers must not be merged, because their cycles differ, their legal consequences differ, and a company that tracks only one of them will inevitably be surprised by the other.

The consequences of mixing the layers are concrete. A portfolio of twenty certificates spread across five issue years can have a renewal due every year, while the company review falls on the same date for the whole portfolio regardless of products. If the two are tracked in one column, the annual review dominates the screen and the product expiries drift out of view, or the reverse. GRZAN builds the two layers as separate recurring series in the compliance calendar, each with its own owner, its own reminder lead times, and its own completion evidence, so that neither layer can silently absorb or eclipse the other. The calendar is then reviewed at a fixed management rhythm, and every certificate file carries a printed copy of its own row.

2. Legal basis

RegulationReference numberPublication dateProvision
Manual para Registro Sanitario de Dispositivos MédicosResolución Ministerial N° 010Current version as published on the AGEMED websiteSection 3.1.5
Manual para Registro Sanitario de Dispositivos MédicosResolución Ministerial N° 010Current version as published on the AGEMED websiteSection 5.7.2
Manual para Registro Sanitario de Dispositivos MédicosResolución Ministerial N° 010Current version as published on the AGEMED websiteSection 3.2.1
Resolución Ministerial (fees and procedures)Resolución Ministerial N° 026525 May 2018Full text

3. Expert insights

Insight one: validity runs from the date of issuance, not from the approval date or the submission date. The wording of Section 3.1.5 is anchored on issuance. Companies entering dates into their compliance calendar must use the issuance date printed on the certificate; using any other date shifts the entire lead-time calculation and can consume the planned preparation window without anyone noticing until the reminder fires late. The certificate itself is the controlling document: where the issuance date on the certificate differs from internal records, the certificate governs, and the discrepancy should be corrected in the calendar on the day it is found.

Insight two: the thirty business days after expiry are a window for maintaining validity, not permission to wait thirty days. The legal effect of the window is that the registration remains valid while the re-registration is processed, but only if the application has been submitted within the window. Once the window passes without a submission, the product stands without a valid registration, with the commercial and customs consequences that follow from that status. The window is a safety net, and treating it as extra runway converts a designed protection into an avoidable lapse. Internal procedures should therefore require the re-registration submission, not merely its preparation, to be evidenced before the expiry date, with the filing receipt attached to the certificate file.

Insight three: re-registration documentation should be rebuilt against the current Manual. The Manual may have been updated since the first registration, and carrying forward old documentation invites observations from the reviewer. GRZAN recommends downloading the current Manual and the current fee schedule before every re-registration and comparing them against the versions used at first submission, so that every difference in forms, content requirements, or fees is identified before the dossier is assembled rather than after an observation is received.

4. Practical recommendations

  1. Build the two-layer certificate calendar: the product layer counting five years from the issuance date, and the company layer fixed on 31 December each year for the annual review, each layer with its own owner and reminders.
  2. Design the re-registration lead time as three months, under the practical estimate used by GRZAN, which covers document rebuilding, translations, fee processing, and at least one round of observations from the authority.
  3. Download the current Manual and the R.M. N° 0265 fee schedule before every re-registration, and perform a version comparison against the first submission, recording the differences in the project file.

A calendar that has never been rehearsed should be treated as untested. Once a year, GRZAN recommends a short drill: pick one certificate at random, walk through what would happen if the expiry were six months away, and confirm that the reminders exist, the owner is current, and the current Manual and fee texts are actually retrievable. The drill takes an hour and regularly exposes small drifts, such as a departed owner or an outdated contact, that would otherwise surface during the real renewal. Compliance calendars decay quietly, and a scheduled rehearsal is the standard countermeasure in the same way that fire drills are the standard countermeasure for buildings. The drill report, one page with findings and fixes, is then attached to the compliance file, where it doubles as evidence of a functioning quality system at the next inspection.

5. Verification checklist

  • □ Does the certificate calendar record the issuance date, rather than the approval or submission date?
  • □ Has an advance reminder been set for the five-year expiry date?
  • □ Has the annual 31 December review node been set up independently for the company?
  • □ Has the re-registration dossier been rebuilt against the current Manual version?
  • □ Have the conditions for the thirty-business-day window after expiry been confirmed?

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers, importers, and authorized representatives with sanitary registration, re-registration, and post-market compliance in Bolivia. For assistance with this topic, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail